Literature DB >> 4540792

Pharmacological evaluation of aprindine (AC 1802) a new antiarrhythmic agent.

A Georges, A Hosslet, G Duvernay.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4540792

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


× No keyword cloud information.
  4 in total

1.  Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction.

Authors:  F Hagemeijer
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

2.  Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.

Authors:  J P Van Durme; M G Bogaert; M T Rosseel
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

Review 3.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

4.  Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS.

Authors:  Hojae Lee; Jae Jin Lee; Na Young Park; Sandeep Kumar Dubey; Taeyong Kim; Kai Ruan; Su Bin Lim; Seong-Hyun Park; Shinwon Ha; Irina Kovlyagina; Kyung-Tai Kim; Seongjun Kim; Yohan Oh; Hyesoo Kim; Sung-Ung Kang; Mi-Ryoung Song; Thomas E Lloyd; Nicholas J Maragakis; Young Bin Hong; Hyungjin Eoh; Gabsang Lee
Journal:  Nat Neurosci       Date:  2021-11-15       Impact factor: 28.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.